Key players in Antiviral Drugs
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Gilead Sciences, Inc. |
gilead.com (opens in a new tab) | 297 reports |
| 2 |  GSK PLC |
gsk.com (opens in a new tab) | 1,254 reports |
| 3 |  Merck & Co., Inc. |
merck.com (opens in a new tab) | 1,320 reports |
| 4 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 5 |  AbbVie Inc. |
abbvie.com (opens in a new tab) | 1,254 reports |
| 6 |  Roche |
roche.com (opens in a new tab) | 1,485 reports |
Also active in Antiviral Drugs
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| Zydus Lifesciences | |
| Strides Pharma | |
| Alembic Therapeutics | |
| Pharmobedient | |
| Msn | |
| Hetero Laboratories Ltd V | |
 Teva Pharmaceutical |
|
 Aurobindo Pharma |
|
| Lupin Ltd | |
| Sunshine | |
| Invagen Pharmaceuticals | |
| Epic Systems Corporation |
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Antiviral Drugs reports by place
One report for each place. Each tile opens that place's report.
Regions 7
Countries 26
Australia report
Brazil report
Canada report
China report
Ecuador report
Egypt report
France report
Germany report
Hong Kong report
India report
Italy report
Japan report
Kenya report
Malaysia report
Mexico report
New Zealand report
Philippines report
Russia report
Saudi Arabia report
Singapore report
South Africa report
Spain report
Thailand report
UAE report
UK report
US report
Compare all 33 places for Antiviral Drugs, with active trials
Get the full Antiviral Drugs report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.